Exploring Clinical Trial Experiences of People With Leiomyosarcoma

An In Depth Study Investigating The Experiences of Patients In Leiomyosarcoma Clinical Trials

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05548179

Enrollment

500

Registered

2022-09-21

Start date

2023-10-31

Completion date

2025-10-31

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leiomyosarcoma

Keywords

leiomyosarcoma

Brief summary

Clinical study participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about leiomyosarcoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with leiomyosarcoma who are invited to take part in medical research will benefit from the analysis of the data.

Interventions

None listed

Study design

Observational model

CASE_CROSSOVER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient has self-identified as planning to enroll in an interventional clinical trial * Patient has been diagnosed with leiomyosarcoma * Patient is a minimum of 18 years or older

Exclusion criteria

* Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient is pregnant * ECOG score of 4

Design outcomes

Primary

Measure	Time frame
Number of patients who decide to enroll in an leiomyosarcoma clinical trial	3 months
Rate of patients who remain in leiomyosarcoma clinical trial to trial completion	12 months

Contacts

Primary ContactMichael B Gill

bask@withpower.com4159004227

Outcome results